Federal Trade Commission Questions Mylan on EpiPen

Mylan said it received a “preliminary” inquiry from the Federal Trade Commission asking about the company’s commercial practices for its EpiPen severe-allergy treatments.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: PAID Source Type: news